About Genome Diagnostics Private Limited
Data last updated:
Genome Diagnostics Private Limited is a private limited company based in New, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 13 November 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC123068. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹49.1 Lakh. It is led by directors Aakanksha Singhal and Anita Singhal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at G – 167B G Block First Floor Street No. 1 Hari Nagar, New, Delhi, India – 110058.
As per the financials filed for FY 2024, the company reported a revenue of ₹70.36 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹16.1 Lakh (net margin -22.9%) and EBITDA of ₹56,635 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹70.71 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomediagnostics.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressG – 167B G Block First Floor Street No. 1 Hari Nagar, New, Delhi, India – 110058
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Genome Diagnostics Private Limited
The main business activity of Genome Diagnostics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Genome Diagnostics Private Limited
Genome Diagnostics Private Limited is audited by Narula & Gupta for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Narula & Gupta | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Genome Diagnostics Private Limited
Genome Diagnostics has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aakanksha Singhal | Director | 19 May 2014 | 12 Years 4 Months | Current |
| Anita Singhal | Director | 12 May 2018 | 8 Years 4 Months | Current |
Financials of Genome Diagnostics Private Limited FY 2024 filings available
Genome Diagnostics Private Limited reported revenue of ₹70.36 Lakh (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Genome Diagnostics Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 11% fall in the latest year. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Genome Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹56,635 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹16.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Genome Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -22.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Genome Diagnostics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Genome Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Genome Diagnostics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2021 | Hdfc Bank Limited | ₹10.71 Lakh | Open |
| 23 Jan 2006 | Others | ₹60 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Genome Diagnostics Private Limited
Employment history and EPFO contributions of people linked to Genome Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Genome Diagnostics Private Limited
Genome Diagnostics has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Genome Diagnostics Private Limited
Genome Diagnostics Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 21 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed against the company by DSS Takara Bio India Private Limited | Disposed |
| High Court of Delhi | Arbitration matter | Filed against the company by an individual | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Genome Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Genome Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Genome Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Genome Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Genome Diagnostics Private Limited
Recent News on Genome Diagnostics Private Limited
Frequently Asked Questions about Genome Diagnostics Private Limited
Genome Diagnostics is an active private limited company based in New, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 13 November 2003 (23+ years old) and is registered under CIN U24239DL2003PTC123068.
Genome Diagnostics reported revenue of ₹70.36 Lakh for FY 2024 (down 11% YoY).
Genome Diagnostics has 2 current directors:
- Aakanksha Singhal - Director
- Anita Singhal - Director
Genome Diagnostics reported a net loss of ₹16.1 Lakh (net margin -22.9%) and EBITDA of ₹56,635 (EBITDA margin 0.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Genome Diagnostics is -30% over three years and -3% over five years. In the latest year (FY 2024) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
No. Genome Diagnostics has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Genome Diagnostics is U24239DL2003PTC123068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genome Diagnostics has 2 court cases on record: 2 filed against it. Most are in the high courts.
Genome Diagnostics was incorporated on 13 November 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.